Perrigo Company PLC (NYSE:PRGO)

82.73
Delayed Data
As of 4:02pm ET
 -0.04 / -0.05%
Today’s Change
63.68
Today|||52-Week Range
95.93
-5.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$12.0B

Company Description

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo on June 28, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Perrigo Co. Plc
Treasury Building
Dublin Dublin 2
P:(531) 709-4000
Investor Relations:
(269) 686-3373

Employees

Shareholders

Mutual fund holders42.58%
Other institutional38.55%
Individual stakeholders11.42%

Top Executives

Uwe RöhrhoffPresident, Chief Executive Officer & Director
Ronald JanishExecutive VP-Global Operations and Supply Chain
Ron L. WinowieckiChief Financial Officer
Thomas FarringtonChief Information Officer & Executive VP
Grainne QuinnChief Medical Officer & Executive Vice President